The Roundup covers notable class action decisions from federal appellate courts and notable Supreme Court class action cert petitions.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

Shares of GSK rose as much as 6.5% on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle ...

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...

Progressive pulmonary fibrosis (PPF) is an increasingly recognised condition, defined in 2022 to address the progression of ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Prescription digital therapeutics for mental health have the potential to increase patient access to care, but major barriers ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

A recent survey by Boehringer Ingelheim India unveiled a concerning lack of awareness ... involving the use of imaging tests such as CT scans and MRIs to determine the stroke's type and extent. The ...

GSK also said it would pay $70 million to settle a related whistleblower lawsuit filed by a Connecticut laboratory ... Sanofi and Boehringer Ingelheim. Lawsuits against the companies began ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of ...